Download the ICS Branding Pack
Open Discussion Session 25 On Demand Nocturia 366 Differences in the prevalence of nocturnal polyuria (NP) in the US by definition: Results from the epidemiology of nocturnal polyuria (EpiNP) study
Open Discussion Session 7 Open Discussion ePosters 107 Relationship of nocturnal polyuria and combination anti-hypertensive drug therapy
Podium Session 21 Male LUTS, Clinical and Basic Science 198 Desmopressin orally disintegrating tablet effectively reduces symptoms of nocturia and prolongs undisturbed sleep in patients with nocturia: results of a randomized placebo-controlled study
Non Discussion Poster Session 31 348 Refractory Overactive Bladder without Hematuria: A Presenting Symptom of Bladder Cancer
Non Discussion Abstract Session 33 Read by Title 981 Is End Stage Bladder the End Stage of Interstitial Cystitis?
Non Discussion Poster Session 32 514 Etiology of Nocturia during Pregnancy Determined by Voiding Diary Analysis
Podium Poster Session 7 LUTS in Women I 63 Relationship Between Overactive Bladder Symptom Severity, Cystometric Bladder Capacity and Detrusor Overactivity
ICS Editorial Board Member
Dr Jeffrey Paul Weiss declared on the Monday 8th January 2024 that they did not have any existing or known future financial relationships or affiliations to disclose (NONE).
Continence Editorial Board
Editorial Board Member
Continence Reports Editorial Board